Melbourne, Australia

Adrian Achuthan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Melbourne. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adrian Achuthan: Innovator in Pain Management

Introduction

Adrian Achuthan is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of pain management through his innovative research and development of pharmaceutical compositions. His work focuses on utilizing specific antibodies to alleviate pain associated with inflammatory conditions.

Latest Patents

Adrian Achuthan holds a patent titled "Method of treatment of pain by administration of a CCL17 specific antibody." This protocol outlines a method for pain management that includes a pharmaceutical composition aimed at ameliorating the sensation of pain. The protocol incorporates the use of a CCL17 signaling antagonist, either alone or in combination with another analgesic compound, to effectively treat pain.

Career Highlights

Adrian Achuthan is affiliated with The University of Melbourne, where he conducts his research and development activities. His work has led to advancements in understanding how CCL17 signaling can be targeted to provide relief from pain. He has been recognized for his innovative approach to pain management.

Collaborations

Adrian collaborates with esteemed colleagues, including Andrew David Cook and John Allan Hamilton. Their combined expertise contributes to the advancement of research in pain management and related fields.

Conclusion

Adrian Achuthan's contributions to pain management through his innovative patent demonstrate his commitment to improving therapeutic options for patients. His work at The University of Melbourne continues to pave the way for future advancements in this critical area of healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…